Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis

Therapy with gemcitabine and nab-paclitaxel (GNP) is the most commonly used palliative chemotherapy, but its advantage in the neoadjuvant setting remains unclear. Accordingly, our aim is to evaluate the impact of first-line neoadjuvant therapy with GNP in patients with borderline resectable (BRPC) a...

Full description

Saved in:

Bibliographic Details
Published in:	Cancers Vol. 13; no. 17; p. 4326
Main Authors:	Damm, Marko, Efremov, Ljupcho, Birnbach, Benedikt, Terrero, Gretel, Kleeff, Jörg, Mikolajczyk, Rafael, Rosendahl, Jonas, Michl, Patrick, Krug, Sebastian
Format:	Journal Article
Language:	English
Published:	Basel MDPI AG 27.08.2021 MDPI
Subjects:	Cancer therapies Chemotherapy Clinical trials Gemcitabine Meta-analysis Metastasis Neuropathy Neutropenia Paclitaxel Pancreatic cancer Patients Radiation therapy Surgery Survival Systematic Review Toxicity United States > US
ISSN:	2072-6694, 2072-6694
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!